ECO Animal Health Group plc (LON:EAH) Insider David Hallas Purchases 15,500 Shares

ECO Animal Health Group plc (LON:EAH) insider David Hallas acquired 15,500 shares of the stock in a transaction dated Monday, December 2nd. The stock was bought at an average cost of GBX 74 ($0.94) per share, with a total value of £11,470 ($14,517.15).

ECO Animal Health Group Stock Up 1.4 %

ECO Animal Health Group stock opened at GBX 73 ($0.92) on Tuesday. ECO Animal Health Group plc has a 1-year low of GBX 60 ($0.76) and a 1-year high of GBX 135 ($1.71). The stock has a market capitalization of £49.45 million, a price-to-earnings ratio of 3,665.00 and a beta of -0.05. The company has a debt-to-equity ratio of 4.31, a current ratio of 2.96 and a quick ratio of 2.14. The business has a fifty day moving average price of GBX 74.68 and a 200-day moving average price of GBX 101.87.

Wall Street Analyst Weigh In

Separately, Shore Capital restated a “buy” rating on shares of ECO Animal Health Group in a research note on Friday.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.